Scientific article
English

Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics

Published inAlzheimer's & dementia, vol. 11, no. 10, p. 1191-1201
Publication date2015
Abstract

Proposed diagnostic criteria (international working group and National Institute on Aging and Alzheimer's Association) for Alzheimer's disease (AD) include markers of amyloidosis (abnormal cerebrospinal fluid [CSF] amyloid beta [Aβ]42) and neurodegeneration (hippocampal atrophy, temporo-parietal hypometabolism on [18F]-fluorodeoxyglucose-positron emission tomography (FDG-PET), and abnormal CSF tau). We aim to compare the accuracy of these biomarkers, individually and in combination, in predicting AD among mild cognitive impairment (MCI) patients.

Citation (ISO format)
PRESTIA, Annapaola et al. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. In: Alzheimer’s & dementia, 2015, vol. 11, n° 10, p. 1191–1201. doi: 10.1016/j.jalz.2014.12.001
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1552-5260
505views
0downloads

Technical informations

Creation25/08/2015 15:50:00
First validation25/08/2015 15:50:00
Update time14/03/2023 23:41:07
Status update14/03/2023 23:41:06
Last indexation31/10/2024 01:29:31
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack